Infertile women often experience chronic stress, which may have a negative impact on general well-being and may increase the burden of infertility. In this open-label, parallel, randomized controlled trial, infertile women aged 18-50 years (median 37 years) were assigned to an 8-week mindfulness-based program (MBP) or no intervention. The primary outcome was stress severity measured by the Lipp's Stress Symptoms Inventory (ISSL). Data were analyzed by modified intent-to-treat principle, which included all cases available to follow-up regardless of adherence to the intervention (62 participants from the MBP group and 37 from the control group). The median number of symptoms of chronic stress recorded in the past month decreased from six (interquartile range 2 to 9) before the MBP to two (interquartile range 1 to 4) after the intervention (p < 0.001, repeated measures analysis of variance with Time × Group interaction). Depressive symptoms also decreased after MBP, whereas general well-being improved (p < 0.01 for both outcomes). Hair cortisol and serum brain-derived neurotrophic factor (BDNF) did not change significantly between preintervention and postintervention. None of the outcomes changed significantly in the control group. MBP was effective in reducing stress and depressive symptoms while increasing general well-being in infertile women.
Jon Kabat-Zinn idealized a mindfulness-based program (MBP) specifically targeted to relieve stress, known as mindfulness-based stress reduction (MBSR) that has been used since the 1980s (Kabat-Zinn & Chapman-Waldrop, 1988; Miller, Fletcher, & KabatZinn, 1995) . More recently, an MBP named "mind-body skills" was created at the Georgetown University School of Medicine in order to promote self-awareness, self-reflection, and self-care (Saunders et al., 2007) . It derived from the original MBSR intervention with the particularities that it does not require hatha yoga as a formal meditation technique and does not have an intensive, full-day session.
This MBP has been translated to Portuguese and validated in Brazil (Paiva et al., 2016) .
The effects of MBPs can be measured by self-report questionnaires, indicating attenuation of stress and depressive symptoms along with improvement in quality of life (Farb et al., 2010; Farb et al., 2007; Fjorback, Arendt, Ornbol, Fink, & Walach, 2011; Homann et al., 2012; Li, Long, Liu, He, & Li, 2016; Paiva et al., 2016) . However, whether
MBPs are effective to reduce stress in infertile women is still uncertain. Previous randomized studies with less than 15 infertile women per group have shown potential benefits of MBPs on "perceived stress" (Shahrestani, Qanbari, Nemati, & Rahbardar, 2012) and "rumination" (Feili, Borjali, Sohrabi, & Farrokhi, 2012) , whereas a more robust study found increased pregnancy rate among women randomly assigned to a mind/body program during their first in vitro fertilization (IVF) treatment (Domar et al., 2011) . Stress measures have also been shown to improve after cognitive behavioral therapy in women with functional hypothalamic amenorrhea (Michopoulos, Mancini, Loucks, & Berga, 2013) and after a MBP in women with polycystic ovary syndrome (Stefanaki et al., 2015) , two diagnoses that frequently overlap with infertility.
Cortisol is the paradigmatic chronic stress hormone and responds to the activation of the hypothalamic-pituitary-adrenal axis (Lee, Kim, & Choi, 2015) . Cortisol can be measured in blood, saliva, or hair samples. Although blood and salivary cortisol levels have circadian fluctuations, hair cortisol accumulates continuously over the process of hair growth, becoming an integrated measure of cortisol levels during months (Harkey, 1993; Russell, Koren, Rieder, & Van Uum, 2012; Sharpley, McFarlane, & Slominski, 2011; Stalder et al., 2017) .
According to a recent meta-analysis, chronic exposure to stress is associated with increased hair cortisol levels, which do not reflect the degree of perceived stress but do correlate with physical measures such as systolic blood pressure (Stalder et al., 2017 ).
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophic factor family that is released during acute stress response, especially in limbic brain areas (Nibuya, Morinobu, & Duman, 1995) .
The main role of BDNF in stressful situations appears to be the protection against stress-induced depressive symptoms (Autry, Adachi, Cheng, & Monteggia, 2009 ). In the circulation, BDNF levels are often reduced in individuals with a spectrum of stress-related psychiatric disorders such as mood and anxiety disorders (Fontenelle et al., 2012; Grassi-Oliveira, Stein, Lopes, Teixeira, & Bauer, 2008; Piccinni et al., 2008; Viola et al., 2014) . In healthy women, plasma-BDNF levels correlate positively with stress coping and resilience (Ma et al., 2016) .
The objective of this study was to evaluate the effects of MBP on behavioral and neuroendocrine indicators of stress in infertile women. All patients included in this study signed an informed consent.
| Participants
The study population consisted of women aged 18-50 with the diagnosis of infertility, defined as failure to become pregnant despite regular sexual intercourse without contraceptive methods after 1 year (Medicine, 2013; Zegers-Hochschild et al., 2017) . The main causes of infertility in patients eligible for the study (n = 178) were male factor (n = 38), anovulation (n = 19), tubal obstruction (n = 26), endometriosis (n = 22), and unexplained infertility (n = 55). All participants were scheduled to start an IVF cycle in the following 6 months at the reproductive endocrinology unit of a teaching hospital in Belo Horizonte, Southeast Brazil. The participants had been infertile for an average of 7 years, had low-to-medium income, lived at the metropolitan area of Belo Horizonte, and 91% were currently married or in cohabiting union. 
| Randomization, allocation, and concealment
The eligible participants that agreed to be enrolled and signed the informed consent were randomly assigned either to the intervention group or the control group (Figure 1 ). The personnel involved in participant enrollment received sequential opaque, sealed envelopes containing the allocation group and was blinded to the envelop contents. Randomization was performed through two computer generated random number lists. The first 54 participants were randomized without any restriction, which resulted in 35 allocations to the intervention group and 19 to the control group. The remaining 124 participants were randomized prespecifying a 1:1 ratio between groups.
The study was open label, but the outcomes were assessed by self-administered questionnaires or by biochemical assays performed by personnel blinded to the participant treatment group.
| Intervention
The MBP intervention was administered to small groups who met for 2 hours weekly during 10 consecutive weeks. The intervention comprised one introductory meeting, eight MBP sessions, and one concluding meeting. The sessions included meditation, relaxation, autogenic training, guided imagery, and biofeedback, as previously described (Paiva et al., 2016; Saunders et al., 2007) . These activities are not specific to infertility, although the participants' concerns about their infertility arise frequently (Paiva et al., 2016) . The control group attended the first and the last meetings but did not attend the MBP sessions. The time interval between allocation and the first group meeting ranged from 1 to 2 weeks.
| Outcome assessment
Participants were surveyed about stress and depressive symptoms, general well-being, hair cortisol levels, and serum BDNF levels at the first and last meetings, that is, 1 week before starting and 1 week after ending the MBP sessions. The questionnaires were self-administered at the hospital in both occasions.
2.6 | Primary outcome 2.6.1 | Stress symptoms Stress symptoms were assessed with the Lipp's Stress Symptoms Inventory (ISSL) that has been originally developed and validated in a representative sample of Brazilian adults and subsequently used in several clinical studies (Macedo & Diez-Garcia, 2014; Solano et al., 2016) . The questionnaire was originally developed and validated in Brazil, so translation was not required. The ISSL questionnaire is divided in three parts, each one focusing on a specific period of time:
the previous 24 hours (12 physical and three psychological symptoms), the previous week (10 physical and five psychological symptoms), and the previous month (12 physical and 11 psychological symptoms). The questions are self-administered, and each item has a "yes" or "no" response. It includes questions about autonomic symptoms (cold extremities and tachycardia), eating disorders, sexual difficulties, irritability, anxiety, tiredness, and others. In addition to quantifying the symptoms, the instrument classifies the test result into five sequential categories, named "no stress," "alertness," "resistance," "near exhaustion," and "exhaustion," according to the predominant symptoms and their duration (Macedo & Diez-Garcia, 2014 
| General well-being
We used the Psychological General Well Being Inventory (PGWBI) that consists of 22 self-administered items related to the previous month, graded 1 to 6. The overall score represents the sum of all items and ranges from 22 to 132. Higher values indicate greater well-being (Lundgren-Nilsson, Jonsdottir, Ahlborg, & Tennant, 2013) . This inventory may also be used to assess quality of life (Petta et al., 2005) .
| Hair cortisol
Hair cortisol was measured in a subset of participants (n = 16) who did not use hair chemicals or frequent shampooing in the last 60 days, which could affect hair cortisol levels (Hoffman, Karban, Benitez, Goodteacher, & Laudenslager, 2014) . Hair sampling and cortisol extraction were performed as previously validated (Sauve, Koren, Walsh, Tokmakejian, & Van Uum, 2007; Veldhorst et al., 2014) . A tuft of approximately 100 strands of hair was cut in the region of the scalp apex as close as possible to the scalp and stored in aluminum foil at room temperature. For cortisol extraction, 2 cm of the proximal FIGURE 1 Flow diagram showing the selection, allocation, and follow-up of the participants portion of each hair sample were cut into powder with a surgical scissor, then 10-mg hair powder were diluted in 1-ml methanol and incubated for 16 hr at 52°C. The supernatant was transferred to a fresh glass tube and incubated at 52°C to evaporate until the sample became completely dry (~24 hr). Dried samples were suspended in 100 μl of phosphate-buffered saline (PBS) to be assayed.
Cortisol levels were measured in duplicate using a commercial ELISA kit (Alpco Diagnostics, Windham, New Hampshire), following the manufacturer's instructions. Reagents were prepared altogether right before the assay, and a face mask was worn by the assay performer to avoid saliva contamination of the test samples. Fifty microlitres of each calibrator, control, and sample and 100 μl of the conjugated working solution were incubated for 45 minutes at room temperature on a plate shaker (200 rpm) and then washed three times with 200 μl of diluted wash buffer per well using an auto washer. The reaction was revealed with tetramethylbenzidine (TMB) substrate, and the optical density was read at 450 nm. The cross-reactivity of other steroids with the kit antibodies did not exceed 13.6% (prednisolone, 13.6%; corticosterone, 7.6%; deoxycorticosterone and progesterone, 7.2%; cortisone, 6.2%; deoxycortisol and prednisone, 5.6%; dexamethasone, 1.6%). All samples were run in the same plate with 8% intraassay coefficient of variation.
| Serum BDNF
Five millilitres of blood were collected between 07:00 and 10:00 a.m.
by venipuncture and centrifuged at 1,000 rpm during 20 minutes. The supernatant (serum) was transferred to a cryotube and stored at −80°C until the assay. BDNF was measured using the Human/Mouse BDNF DuoSet ELISA kit (code DY248, R&D Systems, Minneapolis, Minnesota), following the kit protocol. Serum samples were thawed on the bench until achieving room temperature and homogenized.
The reagents were prepared altogether right before the assay. The capture antibody was diluted in PBS, and the plate was coated with 100 μl of the diluted capture antibody and incubated overnight at room temperature. Afterwards, the plate was washed three times with 400 μl of wash buffer using an auto washer. Then 30 μl of reagent diluent were added into each well. The plate was incubated at room temperature for 1 hour, the wash step was repeated, and 100 μl of each sample or standard were added. After incubation for 2 hours at room temperature, the wash step was repeated and 100 μl of the detection antibody were added. After 2 hours at room temperature, the plate was washed, 100 μl of Streptavidin-HRP were added, and after 20 minutes at room temperature, the reaction was stopped, and the optical density was read at 450 nm (Fontenelle et al., 2012) .
| Sample size
Sample size calculation was performed during the study planning based on the primary outcome (Supporting Information). At least 31 participants per group were needed to detect a minimum difference of three positive symptoms in the ISSL between the two groups or between the two measures (pre and post) of each group with 90% statistical power at 95% confidence level. Because the planned analysis could not be performed without follow-up data, the study was ended only when the required number of participants had attended the follow-up visit.
| Statistical analysis
The results of the study were analyzed by the modified intent-to-treat principle, which includes all subjects randomized and successfully followed regardless of adherence to treatment (Del Re, Maisel, Blodgett, & Finney, 2013 Graphpad version 6 and SPSS version 22 software packages. All tests were two-tailed and p < 0.05 was considered statistically significant.
| RESULTS

| Participant flow
A total of 178 women were evaluated and considered eligible for the study (Figure 1 ). All eligible participants were randomized, 97 were assigned to receive the MBP intervention, and 81 were assigned to the control group. From the MBP group, eight participants did not receive the allocated intervention, 25 discontinued the intervention, and 35 were lost to follow-up. From the control group, 44 women were lost to follow-up. In the end, 62 participants from the MBP group and 37 from the control group returned to follow-up and were available for analysis (Figure 1) . Seven women underwent an IVF cycle during the study period, and two of them (both from the MPB group) returned to the study follow-up. Of those, one had a positive and the other had a negative biochemical pregnancy test.
| Baseline characteristics
The study groups were similar in all demographic and clinical characteristics either comparing the participants that returned to follow-up (Table 1) or comparing all randomized subjects (Table S1 ). Furthermore, the two groups had no differences in baseline stress symptoms (Figure 5b ), or serum BDNF levels (Figure 5d ).
| Primary outcome: Stress symptoms
Stress symptoms were analyzed before and after intervention in both groups. The number of recent symptoms (last 24 hours) decreased in the overall analysis (p < 0.01) but the effect of time did not differ significantly between the two groups ( F = 0.039 for Time × Group interaction, p = 0.894, Figure 2a) . However, MBP resulted in significant decrease of stress symptoms in the past week ( F = 11.4 for Time × Group interaction, p = 0.001, Figure 2b ) and in the past month ( F = 14.6 for Time × Group interaction, p < 0.001, Figure 2c ). In particular, the median number of symptoms of chronic stress perceived in the past month decreased from six (interquartile range 2 to 9) before the MBP to two (interquartile range 1 to 4) after the intervention. Conversely, the control group had no significant change in stress symptoms between the first and the second assessment 3.4 | Secondary outcomes: Depression, general wellbeing, hair cortisol, and serum BDNF Depressive symptoms subsided only in the MBP group, with a 45% decrease in the median BDI score (Figure 3) . In contrast, the control group had no significant change in depressive symptoms between the first and the second evaluation.
At the same time, the MBP group had significant improvement in general well-being (Figure 4) . The PGWBI score increased by approximately 19% in the MBP group, contrasting with no significant change in the control group.
As shown in Figure 5 , hair cortisol levels at baseline were higher among women with symptoms of chronic stress in the "resistance" stage, whereas serum BDNF levels did not vary according to the stress category. In addition, hair cortisol and serum BDNF levels did not change significantly after MBP or no intervention (control). These results remained unchanged after sensitivity analyses excluding women with endometriosis (Rocha et al., 2017) or using antidepressant drugs (Zhou et al., 2017) , which could have affected serum BDNF levels (data not shown).
| DISCUSSION
The findings of the current RCT suggest that an MBP may be effective in reducing self-reported stress symptoms as well as depressive symptoms while improving general well-being in infertile women.
The population of this study has many potential psychological sources of stress. The mean age was 37 years, and the length of infertility was more than 7 years, which means a long process of expectation and frustration together with an increasing pressure imposed by the advancing age and the consequent reduction in treatment success rates (Hourvitz et al., 2009 ). These women might further be stressed by insufficient emotional support from their partners and relatives and/or by financial instability as fertility drugs are very expensive and not covered by health insurance in Brazil (Paiva et al., 2016) . Moreover, the prevalence of depressive and anxiety disorders in women before a new course of assisted reproductive technology may be as high as 40% (Chen, Chang, Tsai, & Juang, 2004) .
Our results show the efficacy of an eight-session MBP to reduce self-reported stress symptoms. The first studies about the effectiveness of mindfulness were conducted by Kabat-Zinn more than three decades ago (Kabat-Zinn, 1982). A review by Holzel et al. (2011) identified some key mechanisms through which mindfulness can affect health, such as attention regulation, body consciousness, emotional regulation by increase in positive reappraisal and non-reactivity to inner experiences, and change of perspective of the self. Functional neuroimaging studies described that the most relevant cerebral areas activated by mindfulness practices are the insula, related to body awareness, several areas of the prefrontal cortex, related to the regulation of emotions, and the anterior cingulate cortex, related to attention (Holzel et al., 2011; Paul, Stanton, Greeson, Smoski, & Wang, 2013; Smith et al., 2018) . Although different people have different self-coping strategies (Daubenmier, Hayden, Chang, & Epel, 2014) , the MBP techniques are focused on training the participants to establish a new perspective of self-emotions with curiosity and no judgment (Paiva et al., 2016) . These techniques are directly related to stress reduction by helping the development of the ability called "capacity of re-evaluation," which is the individual capacity to turn stressful events into beneficial events, giving a new significance and perspective to suffering (Holzel et al., 2011) .
Depression is a common mental disorder and an important contributor to the overall global burden of disease. It is the main cause of disability worldwide, affecting more women than men (Hasin et al., 2018; Kessler, 2003) . Therefore, the amelioration of depressive symptoms after engaging in the MBP was an important finding of the present study. This benefit is possibly related to some abilities acquired through MBP techniques, such as development of decentering capacity (Galhardo, Cunha, & Pinto-Gouveia, 2013; Hayes-Skelton & Graham, 2013) and reduction of cognitive reactivity (Raes, Dewulf, Van Heeringen, & Williams, 2009 ).
The current study also found that the participants of MBP had an increase in general well-being. This result corroborates with previous studies that demonstrated improvements in quality of life after MBP (Henderson et al., 2012; Li et al., 2016; Paiva et al., 2016; Stefanaki et al., 2015) . Depression is one of the main predictors of well-being perception and quality of life (Scalzo, Kummer, Cardoso, & Teixeira, 2009 ); therefore, it is not surprising that the reduction of depressive FIGURE 5 Hair cortisol (a,b) and serum BDNF (c,d) levels. Basal levels (a,c) were analyzed according to the categorization of participants by the stress questionnaire into "no stress" or different stages of chronic stress, namely, "resistance" and "near exhaustion." The categories "alertness" and "exhaustion" had only one participant each and therefore were not analyzed. *p < 0.05 versus "no stress" (Kruskal-Wallis ANOVA followed by Dunn's test). There was no significant change in either biomarker (b,d) after mindfulness-based program or no intervention (control; repeated measures ANOVA)
symptoms after the MBP was accompanied by an improvement in general well-being.
Cortisol is secreted by the adrenal glands in response to chronic stress as a consequence of hypothalamic-pituitary-adrenal activation.
We expected a reduction of hair cortisol levels after MBP intervention, which did not occur. Although stress symptoms and hair cortisol were measured concurrently, these two parameters have different assessment periods as hair samples were long enough to span approximately 60 days of cortisol accumulation, whereas the stress symptom inventory went back to the last 30 days. Maybe more time would be necessary between the end of intervention period and hair collection to detect a reduction on cortisol. In addition, mild changes in hair cortisol might not have been noted due to lack of statistical power, as we measured cortisol in only a small subset of study participants to avoid the interference of hair chemicals.
BDNF is related to stress response and coping (Herman et al., 1989; Jacobson & Sapolsky, 1991; Nibuya et al., 1995; Young, Haskett, Murphy-Weinberg, Watson, & Akil, 1991) . Here we tested whether serum BDNF levels would be affected by the MBP, and we found no change of serum BDNF levels 1 week after concluding the MBP compared with 1 week before starting it. It is noteworthy that serum BDNF levels at baseline were unrelated to stress category in our study population. Similarly, a recent study with cyclists detected acute BDNF release during exercise and showed that intensified training improved the athletes' mood state, however, without modifying their plasma BDNF levels (Piacentini et al., 2016) . The time latency for serum BDNF changes in response to behavioral and cognitive interventions is not clear-cut and probably varies according to the health condition of the individual and the type of therapy (Hakansson et al., 2017; Kobayashi et al., 2005; Sanada et al., 2016; Turakitwanakan, Mekseepralard, & Busarakumtragul, 2015; Yamada, Yoshimura, Nakajima, & Nagata, 2012) .
A recent Cochrane review concluded that the effects of psychological and educational interventions on mental health of infertile women are uncertain due to the low quality of the existing evidence (Verkuijlen et al., 2016) . In fact, only observational studies, nonrandomized trials, or small RCTs with high risk of bias have evaluated such interventions in the specific group of subfertile people (Feili et al., 2012; Galhardo et al., 2013; Li et al., 2016; Pascoe et al., 2017; Shahrestani et al., 2012) . Accordingly, the main methodological strengths of the present study are the RCT design with true randomization, the adequate statistical power of the analyzed sample, the blinding of personnel involved in allocation and outcome assessment, and the modified intention-to-treat analysis.
Nonetheless, the study has some limitations. Performance bias cannot be ruled out because the intrinsic characteristics of the MBP do not permit blinding of the participants. However, this risk is partly mitigated by the use of objective questionnaires that focus on the presence or absence of symptoms rather than perceived distress.
We must also recognize the risk of attrition bias because 44% of the randomized participants were lost to follow-up. However, the baseline characteristics of the MBP and control groups were similar when we compared only the remaining participants that were fully assessed.
Attrition bias may affect the results when the main reason for dropout is some variable that also influences the outcome. In this study, it may be argued that the participants that perceived a greater benefit of the MBP were more likely to remain in the program and return to follow-up, thereby leading us to overestimate the benefits of the intervention. However, the same phenomenon would be expected to happen in the control group, assuming that the participants who remained in the study were more likely to be coping and resilient. In addition, the control group had no significant improvement in the stress or depressive symptoms despite having more participants lost to follow-up.
The findings of the present trial agree with previous evidence showing benefits of behavioral and cognitive therapies to reduce stress and improve quality of life, but they should be extrapolated with caution considering the peculiarities of the study population. MBPs are not substitutes for other therapeutic interventions and are better used as complement to a therapeutic plan. Mindfulness-based therapies act on symptoms and mechanisms shared by many health conditions and the understanding of such mechanisms will help the refinement of MBPs to act on more specific physiological and psychological targets, hopefully with better results (Malinowski, 2013) .
Further studies are also needed to evaluate the effect of MBP on infertile men, because some aspects of the psychological response to infertility may be gender-specific (Martins et al., 2016) .
On the basis of our results, we conclude that in women undergoing infertility treatment the participation in an MBP can reduce selfreported stress symptoms (physical and psychological), reduce depressive symptoms, and improve general well-being.
